Vicks VapoRub will be available in pharmacies across Pakistan in the coming weeks.
Welnox, a Martin Dow Group company, announced that it has entered into a licensing partnership with Procter & Gamble (P&G) for Vicks VapoRub, with availability expected to begin in the coming weeks.
This strategic partnership reinforces Martin Dow’s commitment to expand access to high-quality, reliable healthcare solutions for millions of consumers across the country.
Anwar Zaman, CEO, Welnox, said, “Vicks VapoRub is an iconic brand with enduring equity, and a natural fit with our vision to build a strong, consumer-centric healthcare portfolio. We see significant opportunity to build on its strong foundation and unlock new avenues of growth in Pakistan.”
For generations, Vicks has been a trusted part of family care routines, offering comforting relief during cough and cold. Backed by over 125 years of heritage, Vicks VapoRub is formulated to help provide relief from common cold symptoms such as nasal congestion, cough, headache, body ache, and discomfort associated with breathing.
- Welnox Partners with P&G to License Vicks VapoRub in Pakistan
- Car Sales in Pakistan Surge 79.9% as Auto Production Rises 36.2%
- SBP Holds Policy Rate at 11.5% as Inflation Rises and Global Risks Grow
- The performance and resilience of the banking sector remained intact during H1CY26: SBP
- How can we apply for the PM’s Fuel Relief Subsidy Scheme?
